Nasal sinus mucosal barrier function and tight junctions that had been destroyed by particulate matter could be restored via Nrf2 administration, indicating that activation of the Nrf2 pathway may be a potential therapeutic target for CRS [91]. Here, NFE2L2 is linked to congenital rubella syndrome.